Molecular basis for gating of cardiac ryanodine receptor: underlying mechanisms for gain- and loss-of function mutations

Cardiac ryanodine receptor (RyR2) is a large Ca2+ release channel in the sarcoplasmic reticulum and indispensable for excitation-contraction coupling in the heart. RyR2 is activated by Ca2+ and RyR2 mutations are implicated in severe arrhythmogenic diseases. Yet, the structural basis underlying channel opening and how mutations affect the channel remain unknown. Here, we addressed gating mechanism of RyR2 by combining high-resolution structures determined by cryo-electron microscopy with quantitative functional analysis of channels carrying various mutations in specific residues. We demonstrated two fundamental mechanisms for channel gating: interactions close to the channel pore stabilize the channel to prevent hyperactivity and a series of interactions in the surrounding regions is necessary for channel opening upon Ca2+ binding. Mutations at the residues involved in the former and the latter mechanisms cause gain-of-function and loss-of-function, respectively. Our results reveal gating mechanisms of the RyR2 channel and alterations by pathogenic mutations at the atomic level.

[1]  F. van Petegem,et al.  Pathological conformations of disease mutant Ryanodine Receptors revealed by cryo-EM , 2021, Nature Communications.

[2]  F. van Petegem,et al.  Structural basis for diamide modulation of ryanodine receptor , 2020, Nature Chemical Biology.

[3]  M. Samsó,et al.  Structural mechanism of two gain-of-function cardiac and skeletal RyR mutations at an equivalent site by cryo-EM. , 2020, Science advances.

[4]  H. Ogawa,et al.  Regulatory mechanisms of ryanodine receptor/Ca2+ release channel revealed by recent advancements in structural studies , 2020, Journal of Muscle Research and Cell Motility.

[5]  M. Horie,et al.  Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation. , 2019, Circulation journal : official journal of the Japanese Circulation Society.

[6]  Qiang Zhou,et al.  Molecular basis for allosteric regulation of the type 2 ryanodine receptor channel gating by key modulators , 2019, Proceedings of the National Academy of Sciences.

[7]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[8]  F. van Petegem,et al.  Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry , 2018, PloS one.

[9]  N. Dokholyan,et al.  Ca2+-mediated activation of the skeletal-muscle ryanodine receptor ion channel , 2018, The Journal of Biological Chemistry.

[10]  M. Horie,et al.  Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1 - Modified Schwartz Score. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[11]  M. Horie,et al.  A tryptophan residue in the caffeine-binding site of the ryanodine receptor regulates Ca2+ sensitivity , 2018, Communications Biology.

[12]  M. Iino,et al.  Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels , 2018, Molecular Pharmacology.

[13]  A. Pérez-Riera,et al.  Catecholaminergic polymorphic ventricular tachycardia, an update , 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[14]  G. Meissner The structural basis of ryanodine receptor ion channel function , 2017, The Journal of general physiology.

[15]  A. Marks,et al.  Ca2+ Release Channels Join the 'Resolution Revolution'. , 2017, Trends in biochemical sciences.

[16]  M. Horie,et al.  Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity , 2017, The Journal of general physiology.

[17]  Jianping Wu,et al.  Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2 , 2016, Science.

[18]  J. Frank,et al.  Structural Basis for Gating and Activation of RyR1 , 2016, Cell.

[19]  M. Iino,et al.  Genotype–Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel , 2016, Human mutation.

[20]  A. J. Williams,et al.  Structural insights into Ca2+-activated long-range allosteric channel gating of RyR1 , 2016, Cell Research.

[21]  W. Hendrickson,et al.  Structures of the colossal RyR1 calcium release channel. , 2016, Current opinion in structural biology.

[22]  X. Bai,et al.  The Central domain of RyR1 is the transducer for long-range allosteric gating of channel opening , 2016, Cell Research.

[23]  M. Samsó,et al.  Ultrastructural Analysis of Self-Associated RyR2s. , 2016, Biophysical journal.

[24]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[25]  Toshihiro Tanaka,et al.  Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes , 2015, PloS one.

[26]  Yigong Shi,et al.  Structure of the rabbit ryanodine receptor RyR1 at near-atomic resolution , 2014, Nature.

[27]  M. Horie,et al.  Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[28]  E. Behr,et al.  Cardiac Evaluation of Pediatric Relatives in Sudden Arrhythmic Death Syndrome: A 2-Center Experience , 2014, Circulation. Arrhythmia and electrophysiology.

[29]  A. Bollmann,et al.  Ryanodine Receptor Mutations Presenting as Idiopathic Ventricular Fibrillation: A Report on Two Novel Familial Compound Mutations, c.6224T>C and c.13781A>G, With the Clinical Presentation of Idiopathic Ventricular Fibrillation , 2014, Pediatric Cardiology.

[30]  Masamichi Ohkura,et al.  Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA , 2014, Nature Communications.

[31]  Yingying Tang,et al.  Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. , 2014, Forensic science international.

[32]  K. Aonuma,et al.  Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[33]  A. Karch,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2013, Neurology.

[34]  Paul D. Adams,et al.  Use of knowledge-based restraints in phenix.refine to improve macromolecular refinement at low resolution , 2012, Acta crystallographica. Section D, Biological crystallography.

[35]  Yongxin Zhao,et al.  An Expanded Palette of Genetically Encoded Ca2+ Indicators , 2011, Science.

[36]  Silvia G Priori,et al.  Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis. , 2011, Circulation research.

[37]  Michael J Ackerman,et al.  The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. , 2009, Journal of the American College of Cardiology.

[38]  M. Endo Calcium-induced calcium release in skeletal muscle. , 2009, Physiological reviews.

[39]  Karen N. Allen,et al.  research papers Acta Crystallographica Section D Biological , 2003 .

[40]  D. Jiang,et al.  Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death , 2007, Proceedings of the National Academy of Sciences.

[41]  Y. Hayashi,et al.  Malignant Hyperthermia in Japan: Mutation Screening of the Entire Ryanodine Receptor Type 1 Gene Coding Region by Direct Sequencing , 2006, Anesthesiology.

[42]  I. Nonaka,et al.  0261 Central core disease is due to RyR1 mutations in more than 90% of patients , 2005, Journal of the Neurological Sciences.

[43]  David N Mastronarde,et al.  Automated electron microscope tomography using robust prediction of specimen movements. , 2005, Journal of structural biology.

[44]  D. Tester,et al.  Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. , 2004, Mayo Clinic proceedings.

[45]  D. Tester,et al.  Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes , 2004, Circulation.

[46]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[47]  Emily F. Farrell,et al.  Ryanodine receptor channelopathies. , 2004, Biochemical and biophysical research communications.

[48]  D. Bers Macromolecular complexes regulating cardiac ryanodine receptor function. , 2004, Journal of molecular and cellular cardiology.

[49]  G. Danieli,et al.  Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias. , 2004, Clinical chemistry.

[50]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[51]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[52]  B. Wallace,et al.  The pore dimensions of gramicidin A. , 1993, Biophysical journal.

[53]  A. Fabiato,et al.  CALCIUM‐INDUCED RELEASE OF CALCIUM FROM THE SARCOPLASMIC RETICULUM OF SKINNED CELLS FROM ADULT HUMAN, DOG, CAT, RABBIT, RAT, AND FROG HEARTS AND FROM FETAL AND NEW‐BORN RAT VENTRICLES * , 1978, Annals of the New York Academy of Sciences.

[54]  S. Eletr,et al.  Phospholipid orientation in sarcoplasmic membranes: spin-label ESR and proton MNR studies. , 1972, Biochimica et biophysica acta.

[55]  A. Leenhardt,et al.  Catecholaminergic Polymorphic Ventricular , 2020, Clinical Cardiogenetics.

[56]  N. Yan,et al.  Modulation of cardiac ryanodine receptor 2 by calmodulin , 2019, Nature.

[57]  J. Frank,et al.  Ryanodine Receptor Structure and Function in Health and Disease. , 2018, Sub-cellular biochemistry.

[58]  M. Horie,et al.  A type 2 ryanodine receptor variant associated with reduced Ca2+ release and short-coupled torsades de pointes ventricular arrhythmia. , 2017, Heart rhythm.

[59]  Y. Ogawa Role of ryanodine receptors. , 1994, Critical reviews in biochemistry and molecular biology.

[60]  G. Meissner,et al.  Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors. , 1994, Annual review of physiology.

[61]  B. Surawicz Ventricular fibrillation. , 1971, The American journal of cardiology.